Загрузка...
Adverse events in a newborn on valproate therapy due to loss-of-function mutations in CYP2C9
An increased risk of valproate-induced toxicity has been reported in children, particularly in those younger than 2 years of age. Significant variations in valproate pharmacokinetics and shifts in the metabolic pathways towards CYP2C9-dependent metabolism seem to play some role in the age-related di...
Сохранить в:
| Опубликовано в: : | Epilepsy Behav Case Rep |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588450/ https://ncbi.nlm.nih.gov/pubmed/26543813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebcr.2015.08.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|